Manager, Global Oncology HEOR & RWE

Job Title: Manager, Global Oncology HEOR & RWE

Job Requisition ID: 1243

Posting Start Date: 3/19/26

At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.

Job Summary

The Manager, Global Oncology HEOR & RWE will work cross-functionally to implement HEOR and RWE projects for the assigned assets under the direction of a Director or Sr. Director of Global Oncology HEOR & RWE. The person will work with clinical, market access, commercial, regional and medical affairs colleagues to support the clinical development and value creation of the company's oncology assets. Responsibilities include the implementation of outcomes research strategies, health economics research planning, and process improvements to ensure patient access to Daiichi Sankyo's products. This individual will ensure that rigorous HEOR studies are conducted to support the clinical and economic value proposition associated with the Daiichi Sankyo Oncology products. The work involves developing global cost effectiveness and budget impact models and to fill data gaps to support access needs, as well as to design and implement global outcomes research & health economic studies that supports key publications, reimbursement strategies. The person will work closely with other members of the Global Market Access & Pricing department to develop RWE and support market access initiatives aligned to Daiichi Sankyo's products, and represent the department in cross functional working groups and committees from time to time.

Responsibilities

HEOR and RWE Deliverables

Support the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products
Conduct or support HEOR and RWE studies such as early economic models, burden of illness studies, external control arms to support single arm trials, and support the development and analysis of patient-reported outcomes (PRO) instruments in clinical trials
Conduct literature reviews to build payer evidence, economic models, and Global Value Dossiers
Support the analysis of clinical trial data for cost effectiveness models and market specific ad-hoc requests for reimbursement submissions
Conduct RWE studies to support the value story for payers and reimbursement submissions
Support the development of global cost effectiveness and budget impact models for HTA submissions to support reimbursement of indications for Daiichi Sankyo’s oncology products
Develop HEOR and RWE communications (e.g. manuscripts, scientific forum presentations, slide decks, symposia), in collaboration with multi-functional teams, to build the peer reviewed published evidence supporting the value propositions for assigned products
Manage vendors in the conduct of HEOR and RWE projects

Evidence Generation & Synthesis

Collaborate cross-functionally to gather overview information of target indications including epidemiology, disease burden, unmet needs, cost of illness, and treatment patterns/pathways
Provide and maintain an in-depth understanding of changing Health Technology Assessments, Reimbursement & Access environment, payer requirements, and policies of key global markets
Conduct evidence gap assessments in collaboration with global functions and key markets/regions

Stakeholder Engagement

Partner with Regional and Global stakeholders to assess and fill HEOR/RWE evidence gaps
Collaborate with Clinical (R&D) to ensure that Payer and reimbursement requirements for key markets are included in the clinical trial / evidence generation plans
Act as an ambassador to drive the access agenda with key stakeholders

Qualifications

Education Qualifications
Bachelor's Degree in relevant discipline (e.g., health economics, medicine, pharmacy, public health, epidemiology) required

Experience Qualifications
4 or more years overall relevant experience or commensurate education/experience required
1 or more years experience in HEOR field (in Healthcare, pharmaceuticals industry, or related) required
Oncology experience, preferably with multi-indication compounds as well as with early-stage compounds
Excellent understanding of the clinical development and life cycle of oncology medicines
Strong knowledge of major markets and their PRA and HTA policies: US and Global (Europe required), both private and government setting
Excellent understanding of HEOR and RWE concepts with hands on experience with HEOR methodologies across all phases of the product life cycle
Track record of successful application of HEOR and RWE with key external stakeholders in major international markets

Travel Requirements
Ability to travel up to 30% of the time. Domestic and global travel

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Salary Range:

USD$137,840.00 - USD$206,760.00

Download Our Benefits Summary PDF

Professionals